Multi-center, Randomized, Double-blind Efficacy and Safety of CD0271 0.3%/CD1579 2.5 % Topical Gel in Acne Vulgaris
Public ClinicalTrials.gov record NCT01880320. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multi-center, Randomized, Double-blind, Parallel-group Vehicle and Active Controlled Study to Compare the Efficacy and Safety of CD0271 0.3% / CD1579 2.5% Topical Gel Versus Topical Gel Vehicle in Subjects With Acne Vulgaris
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The study hypothesis are based on the assumption that : * CD0271 0.3%/CD1579 2.5% Gel provides superior clinical efficacy compared with Topical Gel Vehicle in the overall population and in the subgroup of severe Subjects * CD0271 0.3%/CD1579 2.5% Gel applied once daily for up to 12 weeks has an acceptable safety and tolerability profile
Study identification
- NCT ID
- NCT01880320
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 503 participants
Conditions and interventions
Conditions
Interventions
Drug
Eligibility (public fields only)
- Age range
- 12 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 2013 (Type not available)
- Primary completion
- Mar 2014 (Actual)
- Completion
- Mar 2014 (Actual)
- Last update posted
- Jun 28, 2018
2013 – 2014
United States locations
- U.S. sites
- 25
- U.S. states
- 17
- U.S. cities
- 25
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Galderma Investigational site | Birmingham | Alabama | — | — |
| Galderma Investigationnal Site | Mobile | Alabama | — | — |
| Galderma investigational Site | Hot Springs | Arkansas | — | — |
| Galderma Investigational Site | Los Angeles | California | — | — |
| Galderma Investigational Site | Sacramento | California | — | — |
| Galderma Investigational Site | Santa Monica | California | — | — |
| Galderma Investigational Site | Miami | Florida | — | — |
| Galderma Investigational Site | Miramar | Florida | — | — |
| Galderma Investiogational Site | Newnan | Georgia | — | — |
| Galderma Investigational Site | Snellville | Georgia | — | — |
| Galderma Investigational Site | Chicago | Illinois | — | — |
| Galderma Investigational Site | Detroit | Michigan | — | — |
| Galderma Investigational Site | Albuquerque | New Mexico | — | — |
| Galderma Investigational Site | New York | New York | — | — |
| Galderma Investigational Site | Stony Brook | New York | — | — |
| Galderma Investigational Site | Raleigh | North Carolina | — | — |
| Galderma Investigational Site | Beachwood | Ohio | — | — |
| Galderma investigational Site | Hershey | Pennsylvania | — | — |
| Galderma Investigational Site | Greenville | South Carolina | — | — |
| Galderma Investigational Site | Goodlettsville | Tennessee | — | — |
| Galderma Investigational Site | Knoxville | Tennessee | — | — |
| Galderma Investigational Site | Arlington | Texas | — | — |
| Galderma Investigational Site | San Antonio | Texas | — | — |
| Galderma Investigational Site | Salt Lake City | Utah | — | — |
| Galderma Investigational Site | Spokane | Washington | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 6 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01880320, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 28, 2018 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01880320 live on ClinicalTrials.gov.